Abstract
New derivatives of N‐benzo[d]isothiazol‐3‐yl‐benzamidine 6 a were synthesized as nonacidic anti‐inflammatory/antidegenerative agents. We investigated the influence of the amidines 6 a–j on the production of NO, PGE2, MMP‐3, COX‐2, ROS, and GAGs, key molecules involved in cartilage destruction in osteoarthritic diseases. The antidegenerative properties of the novel designed derivatives 6 b–j were improved with respect to N‐benzo[d]isothiazol‐3‐yl‐benzamidine 6 a. All of the compounds 6 a–j promoted the reduction of most of the IL‐1β‐induced harmful effects. Derivatives 6 d, 6 h, and 6 j were the most potent of all the tested compounds, particularly in the human chondrocyte culture model.

This publication has 17 references indexed in Scilit: